Testing effectiveness (Phase 2)Study completedNCT00496873What this trial is testingEvaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanWho this might be right forLymphoma M.D. Anderson Cancer Center 100
Early research (Phase 1)Study completedNCT00791011What this trial is testingPhase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or VorinostatWho this might be right forHodgkin's LymphomaLow Grade LymphomaLymphoma+3 more Amgen 33
Testing effectiveness (Phase 2)Study completedNCT00022581What this trial is testingThalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)UnknownNCT00026429What this trial is testingDenileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Pharmatech Oncology
Not applicableEnded earlyNCT00038883What this trial is testingCampath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesWho this might be right forLeukemia, Lymphocytic, ChronicLeukemia, Lymphocytic, AcuteLymphoma, Low-Grade+2 more M.D. Anderson Cancer Center 19
Large-scale testing (Phase 3)UnknownNCT00003639What this trial is testingCombination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Scotland and Newcastle Lymphoma Group 200
Early research (Phase 1)Study completedNCT00334438What this trial is testingBortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma UNC Lineberger Comprehensive Cancer Center 12
Not applicableStudy completedNCT00240591What this trial is testingPatients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 TositumomabWho this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT01224821What this trial is testingDosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade HistologiesWho this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 47
Not applicableStudy completedNCT00327132What this trial is testingProspective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeWho this might be right forGastric MALT Lymphoma National Health Research Institutes, Taiwan 47
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Testing effectiveness (Phase 2)Study completedNCT00026351What this trial is testingPentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Pharmatech Oncology
Large-scale testing (Phase 3)UnknownNCT00317096What this trial is testingFCM Versus R-FCM Followed by R-Maintenance or Observation OnlyWho this might be right forLymphoma, FollicularLymphoma, Low-GradeLymphoma, Intermediate-Grade Ludwig-Maximilians - University of Munich 319
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)Study completedNCT00003204What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaWho this might be right forStage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+5 more National Cancer Institute (NCI) 515
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00546793What this trial is testingPh I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLWho this might be right forNHLLymphoma, Non-HodgkinLymphoma, B-Cell+15 more Gilead Sciences 32
Early research (Phase 1)Study completedNCT01682746What this trial is testingPhotodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsWho this might be right forBrain Tumor, Recurrent Harry T Whelan, MD 5
Testing effectiveness (Phase 2)Study completedNCT00058305What this trial is testingBryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+9 more National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00546377What this trial is testingPentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell CancerWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 50